Latest Pfizer Inc. Stories
MUMBAI, India and BALTIMORE, December 11, 2014 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
Leading gene therapy Company will partner with established market leader to develop a potential new treatment paradigm for hemophilia B PHILADELPHIA, Dec.
GOSSELIES, Belgium, Dec. 8, 2014 /PRNewswire/ -- iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc.
Pharmaceutical Veteran to Lead Global Provider of Specialty Clinical Trial Services NEWTOWN, Pa., Dec.
Survey Suggests Need to Reduce Barriers in Addressing Sexual Health Conditions WASHINGTON, Nov.
LOS ANGELES, Nov.
Global Epilepsy Market 2014-2018 profiles key players like GlaxoSmithKline plc, Pfizer Inc. and UCB SA.
CUPERTINO, Calif., Oct. 27, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) reported today that Pfizer Inc. (NYSE: PFE) announced today that it has notified Pain Therapeutics, Inc.
The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the cholesterol-lowering statin medication. New
- A trick or prank.